Nontuberculous Mycobacterium Diseases and Chronic Thromboembolic Pulmonary Hypertension

  • Kuroda Fuminobu
    Department of Respiratory Medicine, Chibaken Saiseikai Narashino Hospital, Japan Department of Respirology, Graduate School of Medicine, Chiba University, Japan
  • Tanabe Nobuhiro
    Department of Respirology, Graduate School of Medicine, Chiba University, Japan
  • Igari Hidetoshi
    Department of Respiratory Medicine, National Hospital Organization Chiba-East National Hospital, Japan
  • Sakurai Takayuki
    Department of Respirology, Graduate School of Medicine, Chiba University, Japan
  • Sakao Seiichiro
    Department of Respirology, Graduate School of Medicine, Chiba University, Japan
  • Tada Yuji
    Department of Respirology, Graduate School of Medicine, Chiba University, Japan
  • Kasahara Yasunori
    Department of Respirology, Graduate School of Medicine, Chiba University, Japan
  • Tatsumi Koichiro
    Department of Respirology, Graduate School of Medicine, Chiba University, Japan

この論文をさがす

抄録

Objective We aimed to investigate the incidence and clinical characteristics of nontuberculous mycobacterial (NTM) pulmonary disease as a complication of chronic thromboembolic pulmonary hypertension (CTEPH).<br> Methods We conducted a retrospective study of 10 cases (5.6%) complicated by NTM pulmonary disease among 180 CTEPH patients.<br> Results Isolated species of avium (n=5), kansasii (n=2), intracellulare (n=1), abscessus (n=1) and fortuitum (n=1) were detected. NTM-infected lesions were observed in 33 of 180 (18.3%) lung segments obtained from the 10 patients, and complete obstruction due to chronic pulmonary thromboembolism was detected in 65 of the 180 segmental pulmonary arteries (36.1%). The NTM-infected segments in the CTEPH patients were significantly associated with obstructed rather than unobstructed pulmonary artery segments [25 of 65 (38.5%) vs. 8 of 115 (6.9%), p<0.01]. Cavitary, nodular, ectatic and ground-glass lesions were seen in 14, 22, seven and four of the 180 segments, respectively. Thirteen of the 14 cavitary (92.9%) lesions were located in non-perfused segments. Five patients with NTM disease underwent pulmonary endarterectomy (PEA). Of the 18 assessable NTM-infected segments in six NTM-treated patients, 17 were located in non-perfused segments and one was located in a previously perfused segment. All NTM-infected segments improved among three segments reperfused with PEA. In contrast, only eight (57.1%) NTM-infected segments improved among 14 continuously non-perfused segments. A lower body mass index was found to be a significant risk factor for NTM disease in the CTEPH patients.<br> Conclusion This is the first report to document NTM-disease complications in patients with CTEPH. Reperfusion in cases of NTM lesions may improve the response to NTM drug therapy.<br>

収録刊行物

  • Internal Medicine

    Internal Medicine 53 (20), 2273-2279, 2014

    一般社団法人 日本内科学会

被引用文献 (2)*注記

もっと見る

参考文献 (21)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ